Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Sanchez

Showing results (221-230 of 319) with videos related to

Pageof 32
Sort By:
Microbes and Infection|September 23, 2016
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infectionMara Biasin, Manuela Sironi, Irma Saulle, et al.
Plos Pathogens|August 8, 2020
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV controlBruna Oriol-Tordera, Maria Berdasco, Anuska Llano, et al.
Open Forum Infectious Diseases|July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention TrialsValeria D Cantos, Moni Neradilek, Yunda Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell ResponsesBruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells, et al.
Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.
Journal of Virology|February 28, 2006
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus controlRosario Zuñiga, Aldo Lucchetti, Patricia Galvan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 22, 2022
Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipientsDavid B Banach, Fidel Lopez-Verdugo, Jorge Sanchez-Garcia, et al.
Science (New York, N.Y.)|October 1, 2005
AIDS. Promote HIV chemoprophylaxis research, don't prevent itRobert M Grant, Susan Buchbinder, Willard Cates, et al.
Annals of the American Thoracic Society|February 3, 2018
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere TrialsRuth N Moro, Nigel A Scott, Andrew Vernon, et al.
Plos One|February 28, 2019
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I allelesCamille Tumiotto, Bruna M Alves, Patricia Recordon-Pinson, et al.
Pageof 32

Showing results (221-230 of 319) with videos related to

Sort By:
Pageof 32
Microbes and Infection|September 23, 2016
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infectionMara Biasin, Manuela Sironi, Irma Saulle, et al.
Plos Pathogens|August 8, 2020
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV controlBruna Oriol-Tordera, Maria Berdasco, Anuska Llano, et al.
Open Forum Infectious Diseases|July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention TrialsValeria D Cantos, Moni Neradilek, Yunda Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell ResponsesBruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells, et al.
Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.
Journal of Virology|February 28, 2006
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus controlRosario Zuñiga, Aldo Lucchetti, Patricia Galvan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 22, 2022
Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipientsDavid B Banach, Fidel Lopez-Verdugo, Jorge Sanchez-Garcia, et al.
Science (New York, N.Y.)|October 1, 2005
AIDS. Promote HIV chemoprophylaxis research, don't prevent itRobert M Grant, Susan Buchbinder, Willard Cates, et al.
Annals of the American Thoracic Society|February 3, 2018
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere TrialsRuth N Moro, Nigel A Scott, Andrew Vernon, et al.
Plos One|February 28, 2019
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I allelesCamille Tumiotto, Bruna M Alves, Patricia Recordon-Pinson, et al.
Pageof 32